Legal help and peer support to improve HIV prevention and care among Latin Americans
Tests legal services with peer navigation for Latin Americans needing HIV prevention or care.
Plain-language title generated from the registry record
Registry title: El Camino HIV Prevention and Care Study
Key facts
- Where
- Berkeley and Washington D.C., United StatesSee the 2 sites
Where in United States
- Oasis Legal ServicesBerkeley, United StatesNot yet recruiting
- La Clinica Del PuebloWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- American University
- Trial code
- NCT07834853
- Record updated
- 22 September 2026
- Original description
The Camino Study evaluates a status-neutral, multi-level pilot intervention designed to improve HIV prevention and care engagement among Latin Americans with unmet HIV prevention and care needs. The intervention combines legal services with peer navigation to reduce fear of healthcare engagement, reduce stress, and improve access to HIV prevention and care services.Read full original descriptionShow less
Evaluating the Camino Intervention to Reduce HIV Risk and Poor Care Outcomes Among Latin Americans
The Camino Study evaluates a status-neutral, multi-level pilot intervention designed to improve HIV prevention and care engagement among Latin Americans with unmet HIV prevention and care needs. The intervention combines legal services with peer navigation to reduce fear of healthcare engagement, reduce stress, and improve access to HIV prevention and care services.
The study will enroll 50 Latin American participants in the Washington, DC, and Oakland, California areas. Using a quasi-experimental wait-list control design, the study will compare HIV outcomes among participants who receive the Camino intervention with those on a rolling waitlist over 18 months. Primary outcomes include HIV testing within the past six months and uptake of pre-exposure prophylaxis (PrEP), as well as HIV care visit attendance, antiretroviral therapy (ART) adherence, and viral load among people living with HIV. The study will also examine legal, social, and mental health factors associated with HIV prevention and care engagement and assess the feasibility of testing the intervention at a larger scale.
Inclusion: Age 18 years or older; Assigned male sex at birth; Identifies as a Latin American man who has sex with men, transgender woman, or nonbinary person on the feminine spectrum; Not a U.S. citizen; Speaks Spanish or English; Resides in the Washington, DC metropolitan area or San Francisco Bay Area; Willing to receive health and/or supportive services through participating study partners; Willing to allow the study to obtain relevant medical record information; Meets one of the following HIV prevention or care criteria:; Living with HIV and either not linked to HIV care, has missed an HIV care appointment within the past year, is not taking antiretroviral therapy (ART), or has a detectable viral load; or Not living with HIV, is sexually active, and is either not taking pre-exposure prophylaxis (PrEP) or has not received an HIV test within the past 6 months.
Exclusion: Younger than 18 years; Does not meet the inclusion criteria above.